Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

GM1 and the aged brain

M Hadjiconstantinou1, N H Neff

  • 1Department of Psychiatry, Ohio State University College of Medicine and Public Health, Columbus 43210, USA.

Annals of the New York Academy of Sciences
|July 21, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The DIAMONDS intervention for type 2 diabetes for people with severe mental illness: findings from a single-group feasibility study.

Frontiers in health services·2025
Same author

EXTending availability of self-management structured EducatioN programmes for people with type 2 Diabetes in low-to-middle income countries (EXTEND)-a feasibility study in Mozambique and Malawi.

BMJ open·2021
Same author

Use of the socio-ecological model to explore factors that influence the implementation of a diabetes structured education programme (EXTEND project) inLilongwe, Malawi and Maputo, Mozambique: a qualitative study.

BMC public health·2021
Same author

Self-monitoring of blood glucose versus self-monitoring of urine glucose in adults with newly diagnosed Type 2 diabetes receiving structured education: a cluster randomized controlled trial.

Diabetic medicine : a journal of the British Diabetic Association·2014
Same author

Transport of 3-methoxy-4-hydroxymandelic acid by isolated rat choroid plexus.

Neurochemical research·2013
Same author

Deuterium-labeled choline: Lack of isotope effects during the synthesis and catabolism of acetylcholine in vivo.

Neurochemical research·2013
Same journal

Multiomics Profiling During Autoimmune Demyelination Highlights a Complex Regulatory Role for Ataxin-1 in B Cells.

Annals of the New York Academy of Sciences·2026
Same journal

Global Trends in Light Pollution and Their Relationship With Socioeconomic Factors.

Annals of the New York Academy of Sciences·2026
Same journal

Wired for Corruption: Inter-Brain Synchrony Encodes Bribery-Related Value Information and Predicts Bribery Agreement.

Annals of the New York Academy of Sciences·2026
Same journal

LM-YOLO: A Lightweight Multi-Scale Enhanced Model for Forest Smoke Detection Using Unmanned Aerial Vehicles.

Annals of the New York Academy of Sciences·2026
Same journal

Polyrhythm Perception and Production: A Scoping Review.

Annals of the New York Academy of Sciences·2026
Same journal

DARTS-CNN-BiLSTM: Intelligent Fault Diagnosis for Computer Numerical Control Machine Tool Feed System.

Annals of the New York Academy of Sciences·2026
See all related articles

GM1 ganglioside treatment improved brain neurotransmitter function in aged rats, reversing cognitive decline and restoring neuron health. This suggests GM1 ganglioside may be a promising therapeutic for age-related neurological symptoms.

Area of Science:

  • Neuroscience
  • Aging Research
  • Neuropharmacology

Background:

  • Aging leads to neurotransmitter dysfunction, particularly cholinergic deficits, contributing to cognitive impairment.
  • Cholinergic system decline is a key factor in age-related cognitive decline and memory loss.

Purpose of the Study:

  • To investigate the effects of GM1 ganglioside on cholinergic neurochemistry and cognitive function in aged rats.
  • To determine if GM1 ganglioside can reverse age-associated deficits in the cholinergic system and neuronal structure.

Main Methods:

  • Aged Sprague-Dawley rats (22-24 months old) received systemic GM1 ganglioside (30 mg/kg, i.p.) daily for 30 days.
  • Assessed cholinergic presynaptic markers (choline acetyltransferase, choline uptake, acetylcholine) in brain and spinal cord.

Related Experiment Videos

  • Evaluated spatial learning and memory, and examined the number and size of cholinergic neurons in basal forebrain and striatum.

    • Main Results:

    • GM1 ganglioside administration enhanced key cholinergic neurochemical markers in aged rats.
    • Treatment significantly improved spatial learning and memory deficits associated with aging.
    • GM1 ganglioside restored the number and size of cholinergic neurons in critical brain regions, with long-lasting effects.

    Conclusions:

    • GM1 ganglioside effectively reverses age-associated cholinergic deficits and cognitive impairment in rats.
    • The neurorestorative effects of GM1 ganglioside on cholinergic neurons are significant and persistent.
    • GM1 ganglioside shows potential as a therapeutic agent for age-related neurological decline.